Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey
- PMID: 15571854
- DOI: 10.1016/j.jhin.2004.07.026
Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey
Abstract
The object of this study was to evaluate the appropriateness of antibiotic use in relation to diagnosis and bacteriological findings in the intensive care units (ICUs) of a 1100-bed referral and tertiary care hospital with an antibiotic restriction policy in Turkey. Between June and December 2002, patients who received antibiotics in the medical and surgical ICUs were evaluated prospectively. Two infectious diseases (ID) specialists assessed the antibiotics ordered daily. Of the 368 patients admitted to the ICUs, 223 (60.6%) received 440 antibiotics. The most frequently prescribed antibiotics were first-generation cephalosporins (16.1%), third-generation cephalosporins (15.2%), aminoglycosides (12.1%), carbapenems (10.7%) and ampicillin-sulbactam (8.7%). Antibiotic use was inappropriate in 47.3% of antibiotics. ID specialists recommended the use of 47% of all antibiotics. An antibiotic order without an ID consultation was more likely to be inappropriate [odds ratio (OR)=13.2, P<0.001, confidence intervals (CI)=4.4-39.5]. Antibiotics ordered empirically were found to be less appropriate than those ordered with evidence of culture and susceptibility results (OR=3.8, P=0.038, CI=1.1-13.1). Inappropriate antibiotic use was significantly higher in patients who had surgical interventions (OR=3.6, P=0.025, CI=1.2-10.8). Irrational antibiotic use was high for unrestricted antibiotics. In particular, antibiotic use was inappropriate in surgical ICUs. Additional interventions such as postgraduate training programmes and elaboration of local guidelines could be beneficial.
Similar articles
-
Changes in antibiotic use, cost and consumption after an antibiotic restriction policy applied by infectious disease specialists.Jpn J Infect Dis. 2005 Dec;58(6):338-43. Jpn J Infect Dis. 2005. PMID: 16377863
-
Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit.Am J Infect Control. 2008 May;36(4):283-90. doi: 10.1016/j.ajic.2007.06.009. Am J Infect Control. 2008. PMID: 18455049
-
Implementation of treatment guidelines to support judicious use of antibiotic therapy.J Clin Pharm Ther. 2010 Feb;35(1):71-8. doi: 10.1111/j.1365-2710.2009.01045.x. J Clin Pharm Ther. 2010. PMID: 20175814
-
Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit?Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S82-8. doi: 10.1086/504484. Clin Infect Dis. 2006. PMID: 16894520 Review.
-
[For rational use of antibiotics in the hospital].Rev Med Brux. 2001 Feb;22(1):15-25. Rev Med Brux. 2001. PMID: 11252901 Review. French.
Cited by
-
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.BMC Infect Dis. 2014 Nov 25;14:615. doi: 10.1186/s12879-014-0615-z. BMC Infect Dis. 2014. PMID: 25420613 Free PMC article.
-
Evaluation of Antibiotic Use Among Sepsis Patients in an Intensive Care Unit: A cross-sectional study at a referral hospital in Indonesia.Sultan Qaboos Univ Med J. 2018 Aug;18(3):e367-e373. doi: 10.18295/squmj.2018.18.03.017. Epub 2018 Dec 19. Sultan Qaboos Univ Med J. 2018. PMID: 30607280 Free PMC article.
-
Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units.Antimicrob Agents Chemother. 2009 Jul;53(7):2887-91. doi: 10.1128/AAC.01430-08. Epub 2009 Apr 13. Antimicrob Agents Chemother. 2009. PMID: 19364846 Free PMC article.
-
Influencing the use of antibiotics in a Chinese pediatric intensive care unit.Pharm World Sci. 2008 Dec;30(6):787-93. doi: 10.1007/s11096-008-9220-9. Epub 2008 May 21. Pharm World Sci. 2008. PMID: 18493864
-
Evaluation of restricted antibiotic use in a hospital in Romania.Int J Clin Pharm. 2015 Jun;37(3):452-6. doi: 10.1007/s11096-015-0096-1. Epub 2015 Apr 2. Int J Clin Pharm. 2015. PMID: 25832678
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical